SCHEMBL5639

SCHEMBL5639

CCC[C@]1(O)CC[C@]2(CCN(c3ccc(CCOC)cc3)C2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.41
CYP3A4 P08684 9/20 0.38
CYP2C19 P33261 3/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 5/20 0.38
USP2 O75604 4/20 0.38
CYP1A2 P05177 4/20 0.38
HSD17B10 Q99714 3/20 0.38
CYP2C9 P11712 3/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
LIPE Q05469 1/20 0.38
MAPK1 P28482 3/20 0.35
KCNH2 Q12809 1/20 0.35
ALOX15 P16050 1/20 0.35
HIF1A Q16665 1/20 0.35
CYP2D6 P10635 2/20 0.34
USP28 Q96RU2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4962 0.85 RYR2 (0.41) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5166 0.85 CYP3A4 (0.37) S1PR1CYP3A4CYP2C19TSHRALDH1A1
SCHEMBL5165 0.85 CYP3A4 (0.37) S1PR1CYP3A4CYP2C19TSHRALDH1A1
SCHEMBL5614 0.79 LIPE (0.60) LIPEKCNH2
SCHEMBL5485 0.79 RYR2 (0.45) S1PR1CYP3A4CYP2C19TSHRALDH1A1
SCHEMBL5655 0.78 CYP3A4 (0.40) S1PR1CYP3A4CYP2C19TSHRALDH1A1
SCHEMBL5651 0.78 LIPE (0.38) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5924 0.77 ITGB3 (0.38) CYP3A4CYP2C19ALDH1A1USP2CYP1A2
SCHEMBL5406 0.76 KCNJ1 (0.39) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5214 0.76 S1PR1 (0.40) S1PR1CYP3A4CYP2C19TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed